Active — Not RecruitingNot Applicable

Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment

Taiwan107 participantsStarted 2018-06-06

Plain-language summary

The prevalence of thyroid cancer has increased in recent decades. Patients with thyroid cancer need to choose between Thyrogen® injection and Eltroxin® withdrawal before radioiodine therapy or scan. This is a prospective, observational study, aiming to observe the difference of metabolic profiles between patients choose Thyrogen® injection and Eltroxin® withdrawal.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with diagnosis of thyroid cancer。
✓. Patients who need radioiodine therapy or scan。

Exclusion criteria

✕. Patients cannot cooperate with blood test.。
✕. Patients cannot cooperate with radioiodine therapy。

What they're measuring

Zung's Self-reported depression scale

Timeframe: 1 month

Trial details

NCT IDNCT03624751

SponsorTaichung Veterans General Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-06-30

View on ClinicalTrials.gov More Thyroid Cancer trials